These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9925993)

  • 21. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
    Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
    Kovoor P; Eipper V; Byth K; Cooper MJ; Uther JB; Ross DL
    Eur Heart J; 1999 Mar; 20(5):364-74. PubMed ID: 10206383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the effect of D,L-sotalol on ventricular tachycardia inducibility from the RR variability response.
    Brembilla-Perrot B; Houriez P; Claudon O; Preiss JP; Beurrier D
    Heart; 1999 Sep; 82(3):307-11. PubMed ID: 10455080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of procainamide and dl-sotalol on the changes of atrial electrophysiology induced by high current stimulation.
    Yu WC; Chen SA; Tai CT; Wen ZC; Feng AN; Ding YA; Chang MS
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2064-9. PubMed ID: 9826857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings.
    Shimizu W; Kurita T; Suyama K; Aihara N; Kamakura S; Shimomura K
    Am J Cardiol; 1996 May; 77(11):1004-8. PubMed ID: 8644624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC; Williamson BD; Niebauer M; Daoud E; Bakr O; Strickberger SA; Hummel JD; Kou W; Morady F
    Am J Cardiol; 1994 Dec; 74(11):1119-23. PubMed ID: 7977070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation.
    Campbell RW; Furniss SS
    Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
    Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of efficacy of sotalol and nifekalant for ventricular tachyarrhythmias.
    Watanabe H; Chinushi M; Washizuka T; Sugiura H; Hirono T; Aizawa Y; Komura S; Hosaka Y; Tanabe Y; Furushima H; Aizawa Y
    Circ J; 2006 May; 70(5):583-7. PubMed ID: 16636494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency-dependent electrophysiologic effects of amiodarone in humans.
    Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
    Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
    Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.